Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Daniela Luminita Zob"'
Publikováno v:
Biomedicines, Vol 12, Iss 9, p 2146 (2024)
Background/Objectives: Immunotherapy has changed the therapeutic approach for various solid tumors, especially lung tumors, malignant melanoma, renal and urogenital carcinomas, demonstrating significant antitumor activity, with tolerable safety profi
Externí odkaz:
https://doaj.org/article/066de48f2489490dbb687b95c4dd0b53
Autor:
Laurentiu Simion, Iolanda Georgiana Augustin, Simona Ruxandra Volovat, Eliza Maria Froicu, Michael Schenker, Laura Mazilu, Cornelia Nitipir, Mirela Zivari, Constantin Volovat, Mihnea Alecu, Bogdan Tanase, Ciprian Cirimbei, Dan Cristian Luca, Dana Lucia Stanculeanu, Daniela Luminita Zob
Publikováno v:
Archives of Breast Cancer. 10:15-25
Background: Alteration of the expression of human epidermal growth factor receptor-2 gene as an oncogenic pathway in breast cancer was first explored in the 1980'. Since then, tremendous progress has been made in treating HER2-positive breast cancer.
Autor:
Daniela Luminita Zob, Iolanda Augustin, Lavinia Caba, Monica-Cristina Panzaru, Setalia Popa, Alina Delia Popa, Laura Florea, Eusebiu Vlad Gorduza
Publikováno v:
International journal of molecular sciences. 24(1)
Melanoma is a common and aggressive tumor originating from melanocytes. The increasing incidence of cutaneous melanoma in recent last decades highlights the need for predictive biomarkers studies. Melanoma development is a complex process, involving
Autor:
Adina Turcu-Stiolica, Maria Bogdan, Elena Adriana Dumitrescu, Daniela Luminita Zob, Victor Gheorman, Madalina Aldea, Venera Cristina Dinescu, Mihaela-Simona Subtirelu, Dana-Lucia Stanculeanu, Daniel Sur, Cristian Virgil Lungulescu
Publikováno v:
International Journal of Environmental Research and Public Health. 19:16832
We performed a meta-analysis of chemo-brain diagnostic, pooling sensitivities, and specificities in order to assess the accuracy of a machine-learning (ML) algorithm in breast cancer survivors previously treated with chemotherapy. We searched PubMed,
Pelvic Exenteration in Advanced, Recurrent or Synchronous Cancers—Last Resort or Therapeutic Option?
Autor:
Vlad Rotaru, Elena Chitoran, Daniela-Luminita Zob, Sinziana-Octavia Ionescu, Gelal Aisa, Prie Andra-Delia, Dragos Serban, Daniela-Cristina Stefan, Laurentiu Simion
Publikováno v:
Diagnostics, Vol 14, Iss 16, p 1707 (2024)
First described some 80 years ago, pelvic exenteration remain controversial interventions with variable results and ever-changing indications. The previous studies are not homogenous and have different inclusion criteria (different populations and di
Externí odkaz:
https://doaj.org/article/df3d08cb080a42ef882e8ee1ff100334